Literature DB >> 27566547

Skeletal Muscle-specific G Protein-coupled Receptor Kinase 2 Ablation Alters Isolated Skeletal Muscle Mechanics and Enhances Clenbuterol-stimulated Hypertrophy.

Benjamin P Woodall1, Meryl C Woodall1, Timothy S Luongo1, Laurel A Grisanti1, Douglas G Tilley1, John W Elrod1, Walter J Koch2.   

Abstract

GRK2, a G protein-coupled receptor kinase, plays a critical role in cardiac physiology. Adrenergic receptors are the primary target for GRK2 activity in the heart; phosphorylation by GRK2 leads to desensitization of these receptors. As such, levels of GRK2 activity in the heart directly correlate with cardiac contractile function. Furthermore, increased expression of GRK2 after cardiac insult exacerbates injury and speeds progression to heart failure. Despite the importance of this kinase in both the physiology and pathophysiology of the heart, relatively little is known about the role of GRK2 in skeletal muscle function and disease. In this study we generated a novel skeletal muscle-specific GRK2 knock-out (KO) mouse (MLC-Cre:GRK2fl/fl) to gain a better understanding of the role of GRK2 in skeletal muscle physiology. In isolated muscle mechanics testing, GRK2 ablation caused a significant decrease in the specific force of contraction of the fast-twitch extensor digitorum longus muscle yet had no effect on the slow-twitch soleus muscle. Despite these effects in isolated muscle, exercise capacity was not altered in MLC-Cre:GRK2fl/fl mice compared with wild-type controls. Skeletal muscle hypertrophy stimulated by clenbuterol, a β2-adrenergic receptor (β2AR) agonist, was significantly enhanced in MLC-Cre:GRK2fl/fl mice; mechanistically, this seems to be due to increased clenbuterol-stimulated pro-hypertrophic Akt signaling in the GRK2 KO skeletal muscle. In summary, our study provides the first insights into the role of GRK2 in skeletal muscle physiology and points to a role for GRK2 as a modulator of contractile properties in skeletal muscle as well as β2AR-induced hypertrophy.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Akt PKB; G protein-coupled receptor (GPCR); adrenergic receptor; mouse; muscle hypertrophy; muscle physiology

Mesh:

Substances:

Year:  2016        PMID: 27566547      PMCID: PMC5063976          DOI: 10.1074/jbc.M116.721282

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

Review 1.  β-Adrenergic modulation of skeletal muscle contraction: key role of excitation-contraction coupling.

Authors:  Simeon P Cairns; Fabio Borrani
Journal:  J Physiol       Date:  2015-11-01       Impact factor: 5.182

2.  In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction.

Authors:  A S Shah; D C White; S Emani; A P Kypson; R E Lilly; K Wilson; D D Glower; R J Lefkowitz; W J Koch
Journal:  Circulation       Date:  2001-03-06       Impact factor: 29.690

3.  Slow to fast alterations in skeletal muscle fibers caused by clenbuterol, a beta 2-receptor agonist.

Authors:  R J Zeman; R Ludemann; T G Easton; J D Etlinger
Journal:  Am J Physiol       Date:  1988-06

4.  In vivo inhibition of elevated myocardial beta-adrenergic receptor kinase activity in hybrid transgenic mice restores normal beta-adrenergic signaling and function.

Authors:  S A Akhter; A D Eckhart; H A Rockman; K Shotwell; R J Lefkowitz; W J Koch
Journal:  Circulation       Date:  1999-08-10       Impact factor: 29.690

5.  Cardiac-specific ablation of G-protein receptor kinase 2 redefines its roles in heart development and beta-adrenergic signaling.

Authors:  Scot J Matkovich; Abhinav Diwan; Justin L Klanke; Daniel J Hammer; Yehia Marreez; Amy M Odley; Eric W Brunskill; Walter J Koch; Robert J Schwartz; Gerald W Dorn
Journal:  Circ Res       Date:  2006-09-28       Impact factor: 17.367

Review 6.  The beta-adrenergic receptor kinase in heart failure.

Authors:  Jason A Petrofski; Walter J Koch
Journal:  J Mol Cell Cardiol       Date:  2003-10       Impact factor: 5.000

7.  Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by beta-adrenergic receptor stimulation and blockade.

Authors:  G Iaccarino; E D Tomhave; R J Lefkowitz; W J Koch
Journal:  Circulation       Date:  1998-10-27       Impact factor: 29.690

8.  GRK2 compromises cardiomyocyte mitochondrial function by diminishing fatty acid-mediated oxygen consumption and increasing superoxide levels.

Authors:  Priscila Y Sato; J Kurt Chuprun; Jessica Ibetti; Alessandro Cannavo; Konstantinos Drosatos; John W Elrod; Walter J Koch
Journal:  J Mol Cell Cardiol       Date:  2015-10-23       Impact factor: 5.000

9.  Control of myocardial contractile function by the level of beta-adrenergic receptor kinase 1 in gene-targeted mice.

Authors:  H A Rockman; D J Choi; S A Akhter; M Jaber; B Giros; R J Lefkowitz; M G Caron; W J Koch
Journal:  J Biol Chem       Date:  1998-07-17       Impact factor: 5.157

10.  Level of G protein-coupled receptor kinase-2 determines myocardial ischemia/reperfusion injury via pro- and anti-apoptotic mechanisms.

Authors:  Henriette Brinks; Matthieu Boucher; Erhe Gao; J Kurt Chuprun; Stéphanie Pesant; Philip W Raake; Z Maggie Huang; Xiaoliang Wang; Gang Qiu; Anna Gumpert; David M Harris; Andrea D Eckhart; Patrick Most; Walter J Koch
Journal:  Circ Res       Date:  2010-09-02       Impact factor: 17.367

View more
  2 in total

Review 1.  Metabolic Pathways and Ion Channels Involved in Skeletal Muscle Atrophy: A Starting Point for Potential Therapeutic Strategies.

Authors:  Ileana Canfora; Nancy Tarantino; Sabata Pierno
Journal:  Cells       Date:  2022-08-18       Impact factor: 7.666

Review 2.  Molecular Mechanisms of Skeletal Muscle Hypertrophy.

Authors:  Stefano Schiaffino; Carlo Reggiani; Takayuki Akimoto; Bert Blaauw
Journal:  J Neuromuscul Dis       Date:  2021
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.